PTC Therapeutics PTCT Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's accretion (amortization) of discounts and premiums, investments?
- PTC Therapeutics (PTCT) reported accretion (amortization) of discounts and premiums, investments of $4.11M in Q1 2026.
- How has PTC Therapeutics's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- PTC Therapeutics's accretion (amortization) of discounts and premiums, investments increased by 77.9% year-over-year, from $2.31M to $4.11M.
- What is the long-term trend for PTC Therapeutics's accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), PTC Therapeutics's accretion (amortization) of discounts and premiums, investments has grown at a 35.8% compound annual growth rate (CAGR), from -$5.3M to $18.02M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Reflects the periodic adjustment to the carrying value of investment securities to reflect the amortization of premiums or accretion of discounts over the life of the instrument. This adjustment aligns the effective interest yield of the investment portfolio with the stated coupon rates.